Uterine prolapse complicated by endometrial cancer

William Arthur Cliby, Mark K. Dodson, Karl C. Podratz

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: An infrequent clinical dilemma arises when a patient with uterine prolapse that is best treated vaginally is discovered to have coexisting endometrial cancer. Often the underlying cancer is only discovered intraoperatively or postoperatively. We have reviewed our experience in this situation in an effort to evaluate efficacy of treatment, strategies to avoid late postoperative discovery of cancer, and general guidelines for optimal treatment. Study design: At the Mayo Clinic from 1950 to 1993, 54 patients with coexisting endometrial carcinoma underwent vaginal hysterectomy with repairs for uterine prolapse. Results: We have retrospectively reviewed these cases for relevant data and survival analysis. Complete follow-up is available for 53 patients, and there were four recurrences. In 19 patients bilateral oophorectomy was not performed for multiple reasons, and one of these patients had a recurrence. Twenty-five percent of all patients had disease confined to the endometrium, and 80% overall had low-grade lesions with superficial or no myometrial invasion. Of the four recurrences, three would have been considered low risk of extrauterine spread, and it is doubtful that an abdominal approach would have yielded additional useful information. No patient required reoperation for recurrent pelvic relaxation. Conclusion: We believe that for certain selected patients vaginal surgery for uterine prolapse is adequate treatment in the presence of endometrial cancer. We discuss the selection strategies, exclusion criteria, and general guidelines to optimize care for these challenging patients.

Original languageEnglish (US)
Pages (from-to)1675-1683
Number of pages9
JournalAmerican Journal of Obstetrics and Gynecology
Volume172
Issue number6
DOIs
StatePublished - 1995

Fingerprint

Uterine Prolapse
Endometrial Neoplasms
Recurrence
Guidelines
Vaginal Hysterectomy
Ovariectomy
Survival Analysis
Endometrium
Reoperation
Neoplasms
Patient Care

Keywords

  • endometrial cancer
  • procidentia
  • uterine prolapse
  • vaginal hysterectomy

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Uterine prolapse complicated by endometrial cancer. / Cliby, William Arthur; Dodson, Mark K.; Podratz, Karl C.

In: American Journal of Obstetrics and Gynecology, Vol. 172, No. 6, 1995, p. 1675-1683.

Research output: Contribution to journalArticle

Cliby, William Arthur ; Dodson, Mark K. ; Podratz, Karl C. / Uterine prolapse complicated by endometrial cancer. In: American Journal of Obstetrics and Gynecology. 1995 ; Vol. 172, No. 6. pp. 1675-1683.
@article{2409e633b5de42b495bffb057321a3a5,
title = "Uterine prolapse complicated by endometrial cancer",
abstract = "Objective: An infrequent clinical dilemma arises when a patient with uterine prolapse that is best treated vaginally is discovered to have coexisting endometrial cancer. Often the underlying cancer is only discovered intraoperatively or postoperatively. We have reviewed our experience in this situation in an effort to evaluate efficacy of treatment, strategies to avoid late postoperative discovery of cancer, and general guidelines for optimal treatment. Study design: At the Mayo Clinic from 1950 to 1993, 54 patients with coexisting endometrial carcinoma underwent vaginal hysterectomy with repairs for uterine prolapse. Results: We have retrospectively reviewed these cases for relevant data and survival analysis. Complete follow-up is available for 53 patients, and there were four recurrences. In 19 patients bilateral oophorectomy was not performed for multiple reasons, and one of these patients had a recurrence. Twenty-five percent of all patients had disease confined to the endometrium, and 80{\%} overall had low-grade lesions with superficial or no myometrial invasion. Of the four recurrences, three would have been considered low risk of extrauterine spread, and it is doubtful that an abdominal approach would have yielded additional useful information. No patient required reoperation for recurrent pelvic relaxation. Conclusion: We believe that for certain selected patients vaginal surgery for uterine prolapse is adequate treatment in the presence of endometrial cancer. We discuss the selection strategies, exclusion criteria, and general guidelines to optimize care for these challenging patients.",
keywords = "endometrial cancer, procidentia, uterine prolapse, vaginal hysterectomy",
author = "Cliby, {William Arthur} and Dodson, {Mark K.} and Podratz, {Karl C.}",
year = "1995",
doi = "10.1016/0002-9378(95)91399-8",
language = "English (US)",
volume = "172",
pages = "1675--1683",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Uterine prolapse complicated by endometrial cancer

AU - Cliby, William Arthur

AU - Dodson, Mark K.

AU - Podratz, Karl C.

PY - 1995

Y1 - 1995

N2 - Objective: An infrequent clinical dilemma arises when a patient with uterine prolapse that is best treated vaginally is discovered to have coexisting endometrial cancer. Often the underlying cancer is only discovered intraoperatively or postoperatively. We have reviewed our experience in this situation in an effort to evaluate efficacy of treatment, strategies to avoid late postoperative discovery of cancer, and general guidelines for optimal treatment. Study design: At the Mayo Clinic from 1950 to 1993, 54 patients with coexisting endometrial carcinoma underwent vaginal hysterectomy with repairs for uterine prolapse. Results: We have retrospectively reviewed these cases for relevant data and survival analysis. Complete follow-up is available for 53 patients, and there were four recurrences. In 19 patients bilateral oophorectomy was not performed for multiple reasons, and one of these patients had a recurrence. Twenty-five percent of all patients had disease confined to the endometrium, and 80% overall had low-grade lesions with superficial or no myometrial invasion. Of the four recurrences, three would have been considered low risk of extrauterine spread, and it is doubtful that an abdominal approach would have yielded additional useful information. No patient required reoperation for recurrent pelvic relaxation. Conclusion: We believe that for certain selected patients vaginal surgery for uterine prolapse is adequate treatment in the presence of endometrial cancer. We discuss the selection strategies, exclusion criteria, and general guidelines to optimize care for these challenging patients.

AB - Objective: An infrequent clinical dilemma arises when a patient with uterine prolapse that is best treated vaginally is discovered to have coexisting endometrial cancer. Often the underlying cancer is only discovered intraoperatively or postoperatively. We have reviewed our experience in this situation in an effort to evaluate efficacy of treatment, strategies to avoid late postoperative discovery of cancer, and general guidelines for optimal treatment. Study design: At the Mayo Clinic from 1950 to 1993, 54 patients with coexisting endometrial carcinoma underwent vaginal hysterectomy with repairs for uterine prolapse. Results: We have retrospectively reviewed these cases for relevant data and survival analysis. Complete follow-up is available for 53 patients, and there were four recurrences. In 19 patients bilateral oophorectomy was not performed for multiple reasons, and one of these patients had a recurrence. Twenty-five percent of all patients had disease confined to the endometrium, and 80% overall had low-grade lesions with superficial or no myometrial invasion. Of the four recurrences, three would have been considered low risk of extrauterine spread, and it is doubtful that an abdominal approach would have yielded additional useful information. No patient required reoperation for recurrent pelvic relaxation. Conclusion: We believe that for certain selected patients vaginal surgery for uterine prolapse is adequate treatment in the presence of endometrial cancer. We discuss the selection strategies, exclusion criteria, and general guidelines to optimize care for these challenging patients.

KW - endometrial cancer

KW - procidentia

KW - uterine prolapse

KW - vaginal hysterectomy

UR - http://www.scopus.com/inward/record.url?scp=0029057925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029057925&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(95)91399-8

DO - 10.1016/0002-9378(95)91399-8

M3 - Article

VL - 172

SP - 1675

EP - 1683

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -